Determination of cost-effective optimum coagulant dosage for removal of disinfection by-product precursors in water treatment based on the theory of elasticity
Date
2022
Authors
Li, W.
Wang, J.
Xin, H.
Li, T.
Duan, J.
Mulcahy, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of Water Process Engineering, 2022; 47(102782):1-9
Statement of Responsibility
Conference Name
Abstract
Determination of coagulant dosage in drinking water treatment is related to the requirements for drinking water quality as well as the treatment costs. Selection of appropriate coagulant dosages has been an issue for water treatment utilities, though empirical approaches were normally considered or employed. Inspired by the theory of elasticity in microeconomics, this study explored a novel approach for the cost-effective optimum coagulant dosage. This could enable water utilities to achieve the maximum possible removal efficiency of precursors for disinfection by products (DBPs) while maintain an economical dosage without incurring an excessive cost. The relationships between DBP formation potential (DBPFP) and several relevant water quality parameters were first examined and evaluated. UV254 was found the most appropriate DBPFP indicator with the highest correlation coefficients. Based on the relationship of UV254 and DBPFP, an approach for determination of cost-effective optimum coagulant dosage was delineated.
The results showed that use of the cost-effective optimum coagulant dosage, which account for approximately 33% of optimum coagulant dosage, could achieve 79% of maximum removal efficiencies of UV254 for the source waters tested, thereby substantially reducing the formation of DBPs. Further increase the coagulant dosage was believed uneconomical since the increase in UV254 removal was limited. Similar results were obtained with different coagulants and with raw water samples with diverse water qualities. The results suggest that the proposed approach could provide a mathematical tool for cost-effective optimum coagulant dosage control which could at the same time achieve sufficient removal of natural organic matter to reduce DBPs formation.
School/Discipline
Dissertation Note
Provenance
Description
Data source: Supplementary data, https://doi.org/10.1016/j.jwpe.2022.102782
Access Status
Rights
Copyright 2022 Elsevier